The goal of this study is to investigate the effect of hyaluronic acid injection on functional recovery and pain control in patients following knee or shoulder arthroscopy.
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Safety Evaluation
Timeframe: 4, 12 and 24 weeks
Change from baseline to 4 weeks in Haemoglobin concentration
Timeframe: 4 weeks
Change from baseline to 4 weeks in Haematocrit
Timeframe: 4 weeks
Change from baseline to 4 weeks in White Blood Cell (WBC) count
Timeframe: 4 weeks
Change from baseline to 4 weeks in Platelet count
Timeframe: 4 weeks
Change from baseline to 4 weeks in Basophils (differential)
Timeframe: 4 weeks
Change from baseline to 4 weeks in Eosinophils (differential)
Timeframe: 4 weeks
Change from baseline to 4 weeks in Neutrophils (differential)
Timeframe: 4 weeks
Change from baseline to 4 weeks in Lymphocytes (differential)
Timeframe: 4 weeks
Change from baseline to 4 weeks in Monocytes (differential)
Timeframe: 4 weeks
Change from baseline to 4 weeks in Random Blood Glucose
Timeframe: 4 weeks
Change from baseline to 4 weeks in Urea
Timeframe: 4 weeks
Change from baseline to 4 weeks in Creatinine
Timeframe: 4 weeks
Change from baseline to 4 weeks in Aspartate aminotransferase (AST)
Timeframe: 4 weeks
Change from baseline to 4 weeks in Alanine aminotransferase (ALT)
Timeframe: 4 weeks
Change from baseline to 4 weeks in Prothrombin time (PT)
Timeframe: 4 weeks
Change from baseline to 4 weeks in Activated partial thromboplastin time (aPTT)
Timeframe: 4 weeks
Change from baseline to 4 weeks in International normalised ratio (INR)
Timeframe: 4 weeks
Change from baseline to Weeks 4, 12, and 24 in active knee flexion range of motion
Timeframe: Baseline and Weeks 4, 12, 24
Change from baseline to Weeks 4, 12, and 24 in active shoulder abduction range of motion
Timeframe: Baseline and Weeks 4, 12, 24
Change from baseline to Weeks 4, 12, and 24 in active shoulder adduction range of motion
Timeframe: Baseline and Weeks 4, 12, 24
Change from baseline to Weeks 4, 12, and 24 in active shoulder flexion range of motion
Timeframe: Baseline and Weeks 4, 12, 24
Change from baseline to Weeks 4, 12, and 24 in active shoulder extension range of motion
Timeframe: Baseline and Weeks 4, 12, 24
Exploratory Outcome
Timeframe: 4, 12 and 24 weeks
Exploratory Outcome
Timeframe: 4, 12 and 24 weeks
Exploratory Outcome
Timeframe: 4, 12 and 24 weeks